| |
 |
|
Class Information
Number: 424/184.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.)
Description: Subject matter involving an antigen, an epitope, or another immunospecific immunoeffector, such as an immunospecific vaccine, an immunospecific stimulator of cell-mediated immunity, an immunospecific tolerogen, or an immunospecific immunosuppressor.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 424/275.1 |
Allergen or component thereof (e.g., ragweed pollen, etc.) |
194 |
| 424/185.1 |
Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same |
1,794 |
| 424/234.1 |
Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) |
1,046 |
| 424/277.1 |
Cancer cell or component thereof |
385 |
| 424/203.1 |
Combination of antigens from multiple bacterial species (e.g., multivalent bacterial vaccine, etc.) |
209 |
| 424/202.1 |
Combination of antigens from multiple viral species (e.g., multivalent viral vaccine, etc.) |
203 |
| 424/201.1 |
Combination of viral and bacterial antigens (e.g., multivalent viral and bacterial vaccine, etc.) |
134 |
| 424/193.1 |
Conjugate or complex |
846 |
| 424/274.1 |
Fungus, except allergen, or component thereof or substance produced by said fungus (e.g., trichophyton, etc.) |
96 |
| 424/192.1 |
Fusion protein or fusion polypeptide (i.e., expression product of gene fusion) |
970 |
| 424/198.1 |
Hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, neurotransmitter, or fragment thereof |
468 |
| 424/265.1 |
Parasitic organism or component thereof or substance produced by said parasitic organism (e.g., schistosoma, dirofilaria, trichinella, fasciola, ancylostoma, ascaris, etc.) |
250 |
| 424/200.1 |
Recombinant or stably-transformed bacterium encoding one or more heterologous proteins or fragments thereof |
245 |
| 424/199.1 |
Recombinant virus encoding one or more heterologous proteins or fragments thereof |
585 |
| 424/204.1 |
Virus or component thereof |
999 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6953578 |
Materials and methods for detection and treatment of immune system dysfunctions |
Oct. 11, 2005 |
| 6951651 |
CTL epitope analogs |
Oct. 4, 2005 |
| 6951652 |
Vaccine for prevention of gram-negative bacterial infections and endotoxin related diseases |
Oct. 4, 2005 |
| 6949246 |
Compounds and methods for diagnosis of tuberculosis |
Sep. 27, 2005 |
| 6949345 |
Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin |
Sep. 27, 2005 |
| 6946132 |
Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
Sep. 20, 2005 |
| 6942854 |
Orally-administered interferon-tau compositions and methods |
Sep. 13, 2005 |
| 6942858 |
Compositions containing bacteriophages and methods of using bacteriophages to treat infections |
Sep. 13, 2005 |
| 6942861 |
Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability |
Sep. 13, 2005 |
| 6942865 |
Methods and reagents to detect and characterize norwalk and related viruses |
Sep. 13, 2005 |
| 6942866 |
Malaria immunogen and vaccine |
Sep. 13, 2005 |
| 6939546 |
Model for testing immunogenicity of peptides |
Sep. 6, 2005 |
| 6939548 |
Methods to produce high levels of C. difficile toxins |
Sep. 6, 2005 |
| 6939549 |
Immunoprotective recombinant antigen from anaplasma marginale, vaccine compositions and methods of use |
Sep. 6, 2005 |
| 6939852 |
Methods and compositions for the treatment of cerebral palsy |
Sep. 6, 2005 |
| 6936247 |
Filariid anti-P22U antibodies |
Aug. 30, 2005 |
| 6936249 |
Proteins producing an altered immunogenic response and methods of making and using the same |
Aug. 30, 2005 |
| 6936250 |
Vaccines absorbable by the transmucosal way |
Aug. 30, 2005 |
| 6936251 |
Peptide reagent for the detection of human cytomegalovirus (CMV) |
Aug. 30, 2005 |
| 6936252 |
Streptococcus pneumoniae proteins and nucleic acid molecules |
Aug. 30, 2005 |
| 6936257 |
Recombinant Venezuelan equine encephalitis virus vaccine |
Aug. 30, 2005 |
| 6936258 |
Staphylococcus antigen and vaccine |
Aug. 30, 2005 |
| 6936259 |
CAMP factor of Streptococcus uberis |
Aug. 30, 2005 |
| 6936260 |
Vaccine composition |
Aug. 30, 2005 |
| 6936263 |
Th1 inducing natural adjuvant for heterologous antigens |
Aug. 30, 2005 |
| 6936425 |
Attenuated salmonella SP12 mutants as antigen carriers |
Aug. 30, 2005 |
| 6936447 |
Autoinducer molecule |
Aug. 30, 2005 |
| 6936690 |
Molecules of the card-related protein family and uses thereof |
Aug. 30, 2005 |
| 6936707 |
Modified DNA molecule, recombinant containing the same, and uses thereof |
Aug. 30, 2005 |
| 6932971 |
Hapten-carrier conjugates and uses thereof |
Aug. 23, 2005 |
| 6933277 |
Prevention of fetal alcohol syndrome and neuronal cell death with ADNF polypeptides |
Aug. 23, 2005 |
| 6933280 |
Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
Aug. 23, 2005 |
| 6929794 |
IL-12 as an adjuvant for Bordetella pertussis vaccines |
Aug. 16, 2005 |
| 6929795 |
Chimeric gene formed of the DNA sequences that encode the antigenic determinants of four proteins of L. infantum, useful for serologic diagnosis of canine leishmaniosis and protein obtained |
Aug. 16, 2005 |
| 6929799 |
D-alanine racemase mutants of mycobacteria and uses therefore |
Aug. 16, 2005 |
| 6929918 |
Method for diagnosing an adenocarcinoma or a benign prostate pathology |
Aug. 16, 2005 |
| 6923962 |
Signal peptides, nucleic acid molecules and methods for treatment of caries |
Aug. 2, 2005 |
| 6923963 |
Diagnosis of ehrlichia canis and ehrlichia chaffeensis |
Aug. 2, 2005 |
| 6923965 |
Modulators of polysaccharides and uses thereof |
Aug. 2, 2005 |
| 6924118 |
Recombinant intracellular pathogen immunogenic compositions and methods for use |
Aug. 2, 2005 |
| 6921536 |
Lawsonia intracellularis vaccine |
Jul. 26, 2005 |
| 6921538 |
Therapeutic treatments for neuropsychiatric disorders |
Jul. 26, 2005 |
| 6921543 |
Immunomodulatory preparation |
Jul. 26, 2005 |
| 6919080 |
Polypeptide for Haemophilus paragallinarum and process for preparing the same |
Jul. 19, 2005 |
| 6919318 |
Enhancing immune responses to genetic immunization by using a chemokine |
Jul. 19, 2005 |
| 6919429 |
Prostate associated Ets protein |
Jul. 19, 2005 |
| 6916474 |
Antibodies with increased affinities for anthrax antigens |
Jul. 12, 2005 |
| 6916478 |
Vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same |
Jul. 12, 2005 |
| 6916789 |
Peyer's patch and/or M-cell targeting ligands |
Jul. 12, 2005 |
| 6916836 |
Compounds and methods for use thereof in the treatment of viral infections |
Jul. 12, 2005 |
|
|
|
